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Abstract
Acute exposure to ambient fine particulate matter (PM2.5) is tied to cardiovascular morbidity and 
mortality, especially among those with prior cardiac injury. The mechanisms and pathophysiologic 
events precipitating these outcomes remain poorly understood but may involve inflammation, 
oxidative stress, arrhythmia, and autonomic nervous system imbalance. Cardiomyopathy results 
from cardiac injury, is the leading cause of heart failure, and can be induced in heart failure-prone 
rats through sub-chronic infusion of isoproterenol (ISO). To test whether cardiomyopathy confers 
susceptibility to inhaled PM2.5 and can elucidate potential mechanisms, we investigated the 
cardiophysiologic, ventilatory, inflammatory, and oxidative effects of a single nose-only inhalation 
of a metal-rich PM2.5 (580 μg/m3, 4h) in ISO-pretreated (35 days * 1.0 mg/kg/day sc) rats. During 
the 5 days post-treatment, ISO-treated rats had decreased HR and BP and increased pre-ejection 
period (PEP, an inverse correlate of contractility) relative to saline-treated rats. Before inhalation 
exposure, ISO-pretreated rats had increased PR and ventricular repolarization time (QT) and 
heterogeneity (Tp-Te). Relative to clean air, PM2.5 further prolonged PR-interval and decreased 
systolic BP during inhalation exposure; increased tidal volume, expiratory time, heart rate 
variability (HRV) parameters of parasympathetic tone, and atrioventricular block arrhythmias over 
the hours post-exposure; increased pulmonary neutrophils, macrophages, and total antioxidant 
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status one day post-exposure; and decreased pulmonary glutathione peroxidase 8 weeks after 
exposure, with all effects occurring exclusively in ISO-pretreated rats but not saline-pretreated 
rats. Ultimately, our findings indicate that cardiomyopathy confers susceptibility to the oxidative, 
inflammatory, ventilatory, autonomic, and arrhythmogenic effects of acute PM2.5 inhalation.
Keywords
air pollution; particulate matter; cardiovascular; heart rate variability; arrhythmia; autonomic; 
electrocardiography; rats
Introduction
Epidemiological studies have shown that short-term exposure to particulate air pollution is 
associated with heart failure hospitalization and mortality (Burnett et al. 1995; Dominici et 
al. 2006; Goldberg et al. 2000; Shah et al. 2013; Wellenius et al. 2005). For instance, Shah 
and colleagues (2013) found that hospitalization or death related to heart failure increased by 
more than 2% for each 10 μg/m3 increase in short-term ambient PM2.5, with the strongest 
associations observed on the day of exposure. While the mechanisms underlying the 
increased physiological responses of individuals with heart failure to PM exposure remain 
largely unexplained, acute adverse cardiovascular outcomes are generally believed to result 
from physiologic disturbances involving modulation of the autonomic nervous system 
(ANS), cardiac ion channel, and vascular function; myocardial ischemia, oxidative stress 
and inflammation (Brook et al. 2010; Schulz et al. 2005). Given the high and growing 
prevalence of heart failure in the population, scientific investigation is merited to identify 
mechanisms that might explain why individuals with heart failure are at risk from short-term 
exposure to particulate pollution.
Animal models have proven valuable surrogates of human disease and provide a way to 
better understand fundamental biological mechanisms. The Spontaneously Hypertensive 
Heart Failure rat (SHHF, MccCrl-Leprcp) was established as a model of heart failure and has 
found utility in modeling heart failure in man. This model was developed from the 
Spontaneously Hypertensive Rat (SH) and has a phenotype that predisposes to hypertension, 
insulin resistance, and age-dependent cardiomyopathic remodeling of the left ventricle and 
heart failure (Carll et al. 2011b). The SHHF model has been used to demonstrate that 
inhalation of PM induces multiple biochemical and physiological responses (Carll et al. 
2010; Carll et al. 2012; Carll et al. 2013a; Carll et al. 2013b) that can be summarized as 
changes in pulmonary and systemic inflammation, and modulation of autonomic input to the 
heart resulting an increased parasympathetic dominance. However, these investigations were 
limited to the study of diesel exhaust and high doses of residual oil fly ash (ROFA).
The purpose of this study is to examine the biological and physiological effects associated 
with a lower concentration of PM, more consistent with major urban areas throughout the 
world, in a rat model of cardiomyopathy. In the current study, we tested the hypothesis that 
rats with cardiomyopathy would be more susceptible to the cardiovascular effects of metal-
rich PM2.5 than similarly exposed rats with minimal cardiomyopathy. To induce 
cardiomyopathy, young adult heart failure-prone rats were chronically infused with 
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isoproterenol (ISO), a synthetic catecholamine. We assessed the effects of PM2.5 on 
cardiovascular and pulmonary physiology including electrocardiography (ECG), heart rate, 
heart rate variability (HRV, a measure of autonomic modulation of the heart), arrhythmia, 
BP, and ventilatory parameters, as well as on blood and pulmonary biomarkers of injury, 
inflammation, and oxidative stress.
Methods
Animals
Lean male Spontaneously Hypertensive Heart Failure (SHHF, MccCrl-Leprcp, n=48) rats 
were obtained from Charles River Laboratories (CRL, Kingston, NY). These rats acquire 
cardiac hypertrophy by 2 months of age and dilated cardiomyopathy and overt heart failure 
at 18 months (Carll et al. 2012). Intermediately, neurohormonal and sympathetic activation 
compensate for a loss of contractile function and promote myocardial remodeling. SHHF 
rats are more sensitive to cardiopulmonary effects of air pollutants than the normotensive 
and hypertensive strains from which they are derived (Carll et al. 2012), and this 
vulnerability is further accentuated by ISO-induced cardiomyopathy (Carll et al. 2010). 
Based on our previous experience with this model (Carll et al. 2010; Carll et al. 2011a), we 
modified our procedures in the present study to minimize premature mortality and 
incorporate PM exposures at levels more pertinent to environmental exposure.
Study Regimen
At 2-4 weeks after telemeter implantation, infusion pumps were implanted. Pumps were 
surgically removed after 5 weeks of continuous infusion, and all rats received nose-only 
acclimations at 3 d and 4 d post-pump removal. At 5 d post-pump removal, all rats were 
exposed for 4 h to sROFA or clean air. Necropsies occurred at 24 h post-exposure for non-
telemetered rats and at 8 wks post-exposure for telemetered rats. Regimen summary: 
Implant telemeter → Implant infusion pump (ISO or saline) → Remove pump at 42 days → 
5 d later, expose for 4 h to PM or filtered air.
Radiotelemeter Implantation
At 10-11 weeks of age, 20 rats were surgically implanted at CRL with radiotelemeters 
(model TL11M2-C50-PXT, Data Sciences International) capable of transmitting aortic BP, 
ECG, activity, and core body temperature. Surgeries involved catheterization of the 
descending abdominal aorta and subcutaneous ECG placement in an approximate Lead II 
configuration as previously described (Carll et al. 2010). After a 10-day recovery period, the 
20 telemetered rats were shipped with 28 other SHHFs to our AAALAC International-
approved animal facility at the U.S. EPA. At 12-13 weeks of age 9 more rats were implanted 
in-house with radiotelemeters measuring ECG, HR, and core body temperature (model 
TA11CTA-F40) in an approximate ECG Lead II configuration. All studies conformed to the 
guidelines of the U.S. EPA Institutional Animal Care and Use Committee.
Pharmacologic Model of Cardiomyopathy
Similar to our previous studies, continuous sub-chronic infusion with ISO (Carll et al. 2010; 
Carll et al. 2011a) was used to induce cardiomyopathy in heart failure-prone rats. Rats were 
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surgically implanted with subcutaneous osmotic pumps (Alzet Model 2004) as detailed 
elsewhere (Carll et al. 2011a) at 14-15 weeks containing either dl-isoproterenol 
hydrochloride (ISO, 1.0 mg/kg/day; n=24) or saline (0.9% NaCl, n=24). Isoproterenol is a 
synthetic catecholamine that can cause myocardial infarct-like necrosis, cardiac hypertrophy 
and fibrosis while also potentially impairing cardiac performance. Accordingly, systolic 
failure has been observed after a 6 week infusion of ISO (1.2 mg/kg/day s.c.) in previously 
healthy Wistar rats (Takeshita et al. 2008). In the present study, pumps were surgically 
removed after 5 weeks of infusion.
PM2.5 Inhalation Exposure
All rats were acclimated to nose-only restraint cones for 1 h on the third day after infusion 
ended and then again for 2 h on the next day. Five days after the infusion period, rats 
received a single 4-h exposure to either filtered air or 580 μg/m3 of PM2.5 (mass median 
aerodynamic diameter = 2.09 μm, geometric standard deviation = 3.37) in two separate 24-
port nose-only flow-by inhalation chambers (Lab Products, Seaford, DE). All animals were 
allowed 20 min to stabilize in nose-only chambers and monitored by telemetry for the 
following 40 min while receiving filtered air for “Baseline” values. Subsequently, rats 
received either PM2.5 or clean air for 4 h, and filtered air for the 40-min immediately 
thereafter (“Recovery”). PM2.5 was suspended by a dry dust aerosol generator as previously 
described (Ledbetter et al. 1998). The PM2.5 used in this study was synthesized by 
combining metal compounds in molar ratios comparable to those in the historic ROFA 
sample collected as a post-control fugitive stack emission at a Florida Power and Light plant 
burning #6 grade residual oil containing 1% sulfur (Southern Research Institute, 
Birmingham, AL) (Hatch et al. 1985). ROFA-like dust was generated because of an 
insufficient supply of the original ROFA to perform inhalation studies. NiSO4, Fe2SO4, and 
NaVO3 (all from Sigma) were mixed in a porcelain mortar and placed on a rotary agitator 
for 24 h to generate a transition metal–rich PM2.5 suitable for inhalation exposure. During 
exposure, particle concentration was determined gravimetrically on Teflon filters (45-mm 
diameter with 1-μm pore size; VWR Scientific, West Chester, PA) using a Mercer cascade 
impactor (Intox Products, Albuquerque, NM), and real-time PM concentration was 
estimated with an aerosol monitor (Dust Track; TSI Inc., St Paul, MN) on the chamber 
exhaust. In a prior study, H2O- or HCl-extracts from the Teflon filters were analyzed 
quantitatively for 28 metals and sulfur (expressed as sulfate) (Hazari et al. 2009). Mean (± 
SD) of H2O-soluble content of metals and SO4 were as follows: Fe = 1118 ± 210, Ni = 
10,144 ± 947, V = 21,849 ± 2342, and SO4 = 335,077 ± 28,529 μg/g. Mean (± SD) 1M HCl-
soluble content of metals and SO4 in micrograms per gram were as follows: Fe = 135,586 
± 7904, Ni = 12,398 ± 713, V = 89,852 ± 5432, and SO4 = 421,845 ± 22,923 μg/g.
Cardiovascular Physiology
We continuously monitored activity, core body temperature, BP and ECG in conscious rats 
by radiotelemetry from the beginning of infusion to 8 weeks after inhalation exposure to 
PM2.5 (14 weeks after beginning of infusion) when all telemetered rats were euthanized. 
Arterial BP (mean, systolic, diastolic, and pulse pressures), HR, and aortic pre-ejection 
period (PEP) were automatically calculated by software (DataART 3.01; DSI) from pressure 
and ECG waveforms sampled at 1000 Hz for 2 of every 12 min within home cages (n=5/
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group) and 4 of every 10 min during nose-only inhalation exposure (n=5/group). ECG 
waveforms were analyzed with computer software (ECGauto 2.5.1.35; EMKA 
Technologies, Falls Church, VA) that enabled user identification and exclusion of 
arrhythmias and artifacts from automated analysis of ECG morphology and HRV parameters 
as previously detailed (Carll et al. 2012). ECG morphology parameters were based on P, 
QRS, and T waves and included the following: intervals of PR (beginning of P to R), QRS 
(Q to end of S), ST (S to T-peak), QT (Q to T-peak), QTc (HR-corrected QT using Fridericia 
correction), TpTe (T-peak to T-end, a measure of heterogeneity of repolarization) and 
amplitudes of Q, R, T-peak, and ST (mean amplitude between S and T-peak), relative to the 
isoelectric line (10 milliseconds [ms] before beginning of Q). ST negative area was 
calculated as total negative area underneath the isoelectric line from S-nadir to the beginning 
of the T. Q negative area was calculated as total area underneath the isoelectric line from 
beginning of Q to R. T-positive area was also calculated as the area above the isoelectric line 
from begin to end of the T.
HRV analysis generated HR and time-domain measures, including mean time between 
adjacent QRS-complex peaks (RR interval), standard deviation of the RR interval (SDNN), 
square root of the mean of squared differences of adjacent RR intervals (RMSSD), triangular 
index, and percent of adjacent normal RR intervals differing by ≥ 15 ms (pNN15). SDNN 
and triangular index represent overall HRV, whereas RMSSD and pNN15 represent 
parasympathetic influence over HR (Rowan et al. 2007). HRV analysis also provided 
frequency-domain parameters, including low-frequency (LF: 0.200–0.750 Hz) and high-
frequency (HF: 0.75–2.00 Hz), and the ratio of these two frequency domains (LF/HF). For 
frequency-domain analysis, the signal was analyzed with a Hanning window for segment 
lengths of 512 samples with 50% overlapping. LF is generally believed to represent a 
combination of sympathetic and parasympathetic tone, whereas HF indicates cardiac 
parasympathetic (vagal) tone, and LF/HF serves as an index of sympathovagal balance 
(Rowan et al. 2007).
Arrhythmias were identified while blinded to treatment group according to previously 
described criteria (Carll et al. 2012). To facilitate statistical analysis and allow the data to 
converge under the Poisson distribution, zero values for each arrhythmia type within a 
sample interval were converted to 0.1. Arrhythmia frequencies were calculated over specific 
time-matched periods in home cages (pre-inhalation and post-inhalation, 7-h each) and in 
exposure chamber (baseline, mid-exposure, recovery), normalized to adjust for time 
differences between periods and gaps in data, and presented as number of events per hour of 
theoretically continuous ECG waveforms. Each premature beat was counted individually as 
a single event (e.g., 1 bigeminy = 2 ventricular premature beat [VPB] events), whereas 
atrioventricular (AV) or sinoatrial block arrhythmias were counted as one event regardless of 
duration or neighboring events. HRV and ECG morphologic analyses were conducted on 
ECG waveforms collected while rats resided in home cages at 1 day pre-exposure and 
immediately post-exposure during a 7-h time matched period to control for physiologic 
effects of circadian rhythm. ECG data collected within the exposure chamber (5 h 20 min 
total) were also analyzed according to the following periods: baseline (40 min), exposure (4 
h), and recovery (40 min.). All ECG streams with less than 10 s of identifiable conduction 
cycles were excluded from ECG parameter calculation, and streams with less than 1 min of 
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identifiable RR intervals were excluded from HRV analysis. Thorough visual inspection was 
conducted to identify and exclude arrhythmias and artifacts.
Respiratory Physiology
Data were collected on ventilatory parameters by a barometric whole-body plethysmography 
system (Buxco Electronics, Sharon, CT) permitting continuous monitoring of tidal volume, 
breathing frequency, minute volume, and related time parameters of breathing. At 1 d before 
inhalation exposure to PM2.5 or clean air, immediately following a 2-h nose-only 
acclimation, unrestrained rats (n=5 per group) were allowed to stabilize from handling in 
cylindrical plethysmographs for 1 min and then measured for 5 min. On the day of 
inhalation exposure, measurements were replicated immediately post-exposure as previously 
described (Carll et al. 2010). Ventilatory data were acquired again on the day following 
inhalation exposure immediately before necropsies. Daily calibration of plethysmography 
chambers (model PLY3213; Buxco Electronics) preceded every animal loading. A bias flow 
regulator delivered fresh air (1.8 L/min) to each cylindrical chamber, preventing CO2 
buildup within the chamber.
Tissue Collection and Analysis
At approximately 24 h after onset of the 4-h inhalation exposure, non-telemetered rats were 
deeply anesthetized with an ip injection of a sodium pentobarbital/phenytoin solution and 
euthanized by exsanguination. At 8 wk after inhalation exposure, telemetered rats were 
similarly anesthetized and euthanized. Blood, lung lavage fluid, and tissue samples (heart 
and lungs) were collected, processed, and analyzed as previously described (Carll et al. 
2011a; Carll et al. 2012). Bronchoalveolar lavage fluid was processed for biochemical 
analyses, total cell counts, and cell differentials as previously described (Carll et al. 2011a). 
Lavage macrophages, neutrophils, lymphocytes, and eosinophils were enumerated using 
light microscopy (500 cells per sample). To examine for indications of cardiopulmonary 
inflammation, injury, oxidative stress, and risk, multiple biochemical markers were assayed. 
Lavage, serum, and plasma samples were analyzed with a Konelab 30 clinical chemistry 
analyzer (Thermo Clinical Labsystems, Espoo, Finland) as previously described (Carll et al. 
2010; Carll et al. 2011a). Lavage supernatants were analyzed for albumin, lactate 
dehydrogenase activity, N-acetyl-b-d-glucosaminidase activity, total protein, and total 
antioxidant status. Lavage glutathione peroxidase along with serum glutathione peroxidase, 
reductase, and -S-transferase were analyzed as previously described (Jaskot et al. 1983). 
Serum was also analyzed for creatine kinase, C-reactive protein, α-hydroxybutyrate 
dehydrogenase, high- and low-density lipoprotein cholesterol, lactate dehydrogenase-1, total 
protein, myoglobin, sorbitol dehydrogenase, and triglycerides as previously described (Carll 
et al. 2010; Carll et al. 2012). Plasma was analyzed for angiotensin converting enzyme, 
creatinine, and fibrinogen with the Konelab 30 analyzer as well as B-type natriuretic peptide 
(BNP) by ELISA as detailed elsewhere (Carll et al. 2011a; Carll et al. 2012).
Statistics
Time-series telemetry parameter data (HR, BP, PEP, core body temperature) collected during 
and after drug infusion were analyzed using the Fishing License Method (FLM) software as 
previously described (Carll et al. 2010; Nadziejko et al. 2004). Data were analyzed for 4- to 
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24-h significant effects (P < 0.05) of ISO (n=8) relative to saline (n=9) from the beginning of 
infusion until immediately before inhalation exposure. Data collected in home cages from 32 
h pre- until 82 h post-inhalation exposure were also analyzed by FLM for significant 4‐h 
effects of inhalation exposure. The statistical analyses for all remaining data in this study 
were performed using Prism version 4.03 (GraphPad Software Inc., San Diego, CA). Two-
way ANOVA with Bonferroni post hoc test was used to detect significant differences 
between groups in biochemical and cytological endpoints, tissue weight, and arrhythmia 
frequency during inhalation exposure. Repeated measures two-way ANOVA with 
Bonferroni's post hoc test was performed on (1) arrhythmia frequency data over the 7-h pre- 
and post-exposure periods; (2) HRV and ECG morphology parameters during the exposure 
period, including baseline, and recovery periods to examine for between-group differences 
in 1-h means; (3) between-group differences in change in HRV at post-exposure relative to 
pre-exposure (7 h post-exposure means minus 7 h means from time-matched period 1 d 
prior); and (4) plethymosgraph data collected on the day before and immediately after 
inhalation exposure. A value of p < 0.05 was considered statistically significant.
Results
Heart Rate, Ventricular Function and Body Weight during and after ISO Infusion
SO increased HR by 32% (effect estimate ± standard error: +97±5 BPM; Fig. 1), 
contractility by 13% as indicted by a decreased PEP (-5.0±0.2 ms; Fig. 2), and body weight 
by 15% (mean±standard error, ISO: 442±4, Saline: 384±6 g; P < 0.001) relative to saline 
over the entire 35-day infusion. ISO also significantly decreased systolic (effect estimate ± 
standard error: ‐25±3 mmHg) and diastolic (-23±3 mmHg) pressures for the first 3.5 d of 
infusion relative to saline, whereafter pressure normalized until osmotic pump removal 
(Figure 1). Although the groups had equal body mass at the beginning of infusion, ISO 
increased body weight by 15% relative to saline on the final infusion day (ISO: 442±4, 
Saline: 384±6 grams; P < 0.001).
HR returned to pre-infusion rates when ISO infusion ceased, yet, from 3 d post-infusion 
until inhalation exposures began, ISO pretreatment significantly decreased HR by 33 BPM (‐
10%) relative to saline-infused rats. By contrast, PEP rapidly increased relative to saline-
infused rats, peaking at 28 h after pump removal (+4.4 msec, ISO: 45.6±0.3 vs. saline: 
41.2±0.6, P < 0.05) suggesting decreased contractility (Fig. 2). Until inhalation exposures at 
4.5 d post-infusion, ISO pretreatment significantly increased PEP by 9% (+3.7±0.6 msec, P 
< 0.05). ISO pretreatment also significantly decreased systolic BP for 16 h at 3 d after pump 
removal (ISO: 165±3 vs. saline: 183±3 mmHg, P < 0.05) and for 8 h at 4 d post-infusion 
(ISO: 162±2 vs. saline: 177±3 mmHg, P < 0.05) just before inhalation exposure to PM. In 
addition, diastolic pressure was significantly decreased for 4 h at 3.5 d post-ISO (ISO: 
109±2 vs. saline: 122±2 mmHg, P < 0.05).
Immediately prior to inhalation exposures, ISO-treated rats had significantly increased PR 
interval relative to saline-treated rats (48.4±0.8 vs. 44.9 ± 0.9 ms, P = 0.01), as well as 
increased ST (30.3±1.3 vs. 21.9±1.0 ms), QT (49.5±1.3 vs. 42.4±1.5 ms) and TpTe 
(31.6±2.6 vs. 18.1±1.7 ms) intervals (P < 0.01 for all). Accordingly, ISO-treated rats also 
had increased T-area relative to saline-treated rats (1.3±0.3 vs. 0.4±0.2 ms2, P = 0.04). As 
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well, ISO-treated rats retained an 11% greater body mass than saline-treated rats (ISO: 
413±4, Saline: 372±6 grams; P < 0.001) just before inhalation exposure. ISO infusion did 
not affect any parameters of ventilatory function at 4 d after infusion cessation, 
corresponding with immediately after the second acclimation to nose-only exposure (Fig. 4; 
P > 0.05).
Cardiac electrophysiology, Contractility, and Hemodynamics during Particulate Inhalation
At baseline immediately before particulate exposure, but while animals resided in nose-only 
cones, both the ISO-PM and ISO-Air groups had significantly lower HR than saline 
pretreated rats assigned to receive the same inhalant (ISO-PM: 337±8 vs. Sal-PM: 370±10 
BPM; ISO-Air: 327±6 vs. Sal-Air: 379±9 BPM, P < 0.05). There were no significant 
differences between ISO- and saline- pretreated rats in BP at this baseline period. At 1 h and 
2 h of inhalation exposure, PM increased PR interval in ISO-pretreated rats relative to the 
ISO-air (P<0.05) and Sal-PM groups (p<0.05, Fig. 3). PM did not affect the remaining ECG 
intervals (ST, QT, QRS, TpTe), amplitudes (ST segment, T, Q), or areas (negative Q, 
negative ST, positive T-wave) in either the saline- or ISO-pretreated groups (all P > 0.05, 
data not shown). PM inhalation in ISO-pretreated rats significantly decreased systolic BP 
relative to Sal-PM rats at 3 h (173±5 vs. 196±6 mmHg), 4 h (166±6 vs. 192±4 mmHg), and 
the recovery period of inhalation exposure (167±8 vs. 200±7 mmHg; all P < 0.05). No 
similar effects occurred in the ISO-Air group. Additionally, ISO-PM rats had decreased 
diastolic BP at the recovery period of inhalation exposure relative to Sal-PM rats (122±9 vs. 
144±6 mmHg; P < 0.05). At the recovery period, the ISO-PM group appeared to have an 
accentuated decline in HR relative to the ISO-Air group (254±11 vs. 266±18 BPM), but 
these values did not significantly differ (P>0.05).
Autonomic Balance and Arrhythmia during Particulate Inhalation
ISO did not alter measures of HRV or arrhythmia during nose-only baseline or the 
subsequent hours of inhalation exposure relative to saline-pretreated rats of the 
corresponding inhalation exposure. PM did not significantly alter HRV or arrhythmia during 
inhalation exposure regardless of pretreatment (P > 0.05 relative to corresponding 
pretreatment, data not shown).
Ventilatory Function after Particulate Inhalation
Immediately after exposure, PM exposure significantly increased several measures of 
ventilatory function in ISO-pretreated rats (Figure 4). In these rats PM increased tidal 
volume by 43% relative to pre-inhalation and by 33% relative to saline-pretreated rats 
exposed to PM. Exposure to PM in ISO-pretreated rats also increased expiratory time by 
91% from both the air-exposed ISO-pretreated rats and the PM-exposed saline-pretreated 
rats. PM also increased relaxation time to 50% greater than pre-inhalation, to 44% greater 
than the Sal-PM group, and to 49% greater than the ISO-Air group (all P < 0.05). There 
were no significant differences in ventilatory function on the day following exposure.
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Heart Rate, Contractility, and Hemodynamics after Particulate Inhalation
In ISO-pretreated rats, PM decreased HR at 5.5–6 h post-exposure relative to air (Fig. 5; P < 
0.05). Other than this isolated effect, PM did not alter HR, PEP, BP, or pulse pressure over 
the 64 h after nose-only exposure in either saline- or ISO-pretreated rats relative to their 
corresponding air-exposed counterparts (all P > 0.05).
Autonomic Balance and Arrhythmia after Particulate Inhalation
PM inhalation significantly increased the frequency of AV block (non-conducted P-waves) 
in ISO-pretreated rats to 5.7±2.3 events / h over the seven-hour post-exposure period relative 
to both the ISO-Air (1.8±1.0 events/h) and Sal-PM (0.9±0.5 events/h) groups (Fig. 6). Most 
of these AV block arrhythmias (29 of 33) occurred within the first 4 h of rats returning to 
their home cages, and approximately half (17) resembled Second Degree Mobitz type I AV 
block. PM increased RMSSD significantly in ISO pretreated rats at 1–2 h and 3–4 h post-
exposure relative to the ISO-Air group and at 3–3.5 h post-exposure relative to the Sal-PM 
group (Fig. 5). Likewise, pNN15 significantly increased for the ISO-PM group in several 
instances (at 1–2 h and 3–3.5 h post-exposure vs. ISO-Air and at 3–3.5 h post-exposure vs. 
Sal-PM). HF also significantly increased for the ISO-PM group at similar time-points (at 
2.5–3.5 h post-exposure vs. ISO-Air, and at 3–4 h post-exposure vs. Sal-PM; all P < 0.05). 
Additionally, ISO-PM rats had significantly increased LF from 3–4 h post-exposure relative 
to the Sal-PM group and from 3–3.5 h relative to ISO-Air (P < 0.05; data not shown).
Measures of Pulmonary Inflammation, Endogenous Antioxidants, and Injury
At 1 d post-exposure, PM significantly increased pulmonary neutrophils and total 
antioxidant status only in ISO-pretreated rats relative to their corresponding air control (Fig. 
7). The ISO-PM group also significantly exceeded the Sal-PM group in pulmonary 
macrophages. ISO overall increased plasma BNP (a marker of myocardial stretch) at 6 days 
after infusion had ended (P=0.01) without affecting total lavage protein (data not shown, 
P>0.05). Nevertheless, PM with or without ISO pre-treatment did not significantly alter 
plasma BNP or lavage protein (a marker of pulmonary edema) when compared to control 
groups (P>0.05). At 8 wk after nose-only exposure, only the ISO-PM group had 
significantly decreased glutathione peroxidase in lung lining fluid relative to its air-exposed 
counterpart (Fig. 8). At this same time point, PM overall increased circulating glutathione S-
transferase relative to air exposure (P = 0.03), but there were no differences between 
individual treatment groups when controlling for drug pretreatment (Figure 8). There were 
no other significant effects of ISO or PM on biochemical or cytological endpoints examined 
in lavage or blood (P > 0.05).
Gross Pathology
Neither ISO nor PM altered heart-to-body weight ratio at 1 day post-inhalation exposure (6 
days post-infusion). At 8 wk post-inhalation exposure (9 wk post-infusion), overall, ISO 
treatment increased heart-to-body weight ratio by 3.6% (3.47±0.02 mg/g vs. 3.35±0.05 mg/g 
in saline-treated rats; P < 0.05) despite that the ISO-PM group did not significantly differ 
from the Sal-PM group in this measure.
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We demonstrate that catecholamine-induced cardiomyopathy confers susceptibility to 
inhaled PM. Subchronic infusion of isoproterenol (ISO) in heart failure-prone SHHF rats 
caused post-treatment decrements in cardiac mechanical function and ventricular 
repolarization as measured by an increase in the pre-ejection period and QT and TpTe 
intervals, respectively. These effects were consistent with cardiomyopathic changes in 
mechanical function and electrical properties that accompany hypertrophic cardiomyopathy 
and which are commonly associated with increased risk of arrhythmia and sudden cardiac 
death (Savelieva et al. 1998). Thereafter, PM exposure caused significant cardiopulmonary 
changes only in ISO-pretreated rats, including pulmonary inflammation, AV block 
arrhythmias, an acute surge in pulmonary antioxidants, and a chronic depletion of 
pulmonary glutathione peroxidase, whereas PM had no significant effects in saline-
pretreated rats. PM inhalation also caused parasympathetic dominance in ISO-pretreated rats 
but not saline-pretreated rats, as evidenced by prolonged AV conduction and decreased 
systolic BP during PM exposure as well as increased HRV and decreased HR after PM 
exposure.
The current study used lower concentrations of PM than our prior research to reveal that 
inhalation of metal-rich ROFA can cause arrhythmia in heart failure-prone rats with 
preexisting cardiac injury. In an earlier study, exposure of Spontaneously Hypertensive rats 
to ROFA at 26-fold the present concentrations and with similar metal content also caused 
AV block arrhythmias (Farraj et al. 2009). Likewise, two 5-hour exposures to ROFA at 20-
fold higher concentrations than our current study, but with lower Vn, Ni, and Fe and higher 
Zn content also increased AV block in ISO-pretreated heart failure-prone rats (Carll et al. 
2010). We have also found that exposing hypertensive rats to 20% lower concentrations of 
ROFA than the current study does not affect spontaneous arrhythmias but does decrease the 
dose at which aconitine, an arrhythmogenic drug, induces arrhythmia (Hazari et al. 2009). 
More importantly, in a past study with hypertensive rats exposed to higher concentrations of 
sROFA PM, AV block arrhythmias occurred at 6-fold but not at 1.7-fold the current study's 
concentration (Farraj et al. 2011), further suggesting heightened susceptibility in our current 
model. It is also noteworthy that the PM2.5 concentrations in our present study fell well 
below others used to investigate the cardiovascular effects of a similarly metal-rich PM 
(Kodavanti et al. 2002; Muggenburg et al. 2000; Wellenius et al. 2002) and even below some 
recent extremes in urban environments (Johnson 2013; NASA 2013). Together, these 
findings indicate that the inhalation of PM at more environmentally relevant levels has 
greater arrhythmogenicity in the setting of cardiac remodeling.
It is evident from this and our past research that acute inhalation of a variety of air 
pollutants, including diesel exhaust (DE) in its whole or particle-free form, ozone, and 
ROFA, can modulate autonomic neural input to the heart in the rat and shift autonomic 
balance to parasympathetic predominance. These studies collectively suggest that CVD 
and/or cardiac injury predispose animals to pollutant-induced responses consistent with 
parasympathetic dominance, including AV block arrhythmias, decreased BP and HR, 
prolonged PR-interval, increased HRV—which all occurred in at least 3 of our past studies 
(Carll et al. 2012; Carll et al. 2013a; Farraj et al. 2009; Hazari et al. 2009; Lamb et al. 2012)
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—and, presently, changes in pulmonary physiology. While PR is known to increase not only 
with parasympathetic dominance but also with age and arterial stiffness in humans (Gosse et 
al. 2011), we and others (Campen et al. 2003) have noted PR prolongation with increasing 
age, cardiovascular disease, and/or air pollutant exposure in awake rats, with SH rats < DE-
exposed SH < SHHF < DE-exposed SHHF ≈ PM-exposed SHHF < aged SHHF rats (Carll 
et al. 2012; Carll et al. 2013b; Lamb et al. 2012). Interestingly, when PM concentrations are 
below 1 mg/m3, only SHHF rats appear to manifest AV block arrhythmias, which may partly 
derive from their pronounced AV conduction slowing. PM exposure increased tidal volume 
and elicited parasympathetic cardiovascular responses only in ISO-pretreated rats—effects 
consistent with pulmonary irritant reflexes (Coleridge and Coleridge 2011; Widdicombe and 
Lee 2001). The increases in tidal volume may have prolonged expiration through Hering-
Breuer parasympathetic reflexes to pulmonary stretch (Hayashi et al. 1996; Marek et al. 
2008) that can in some cases induce AV block (James et al. 1980). Although arrhythmias 
and parasympathetic influence over HRV did not change during exposure, we cannot rule 
out the possibility that PM enhanced deposition in ISO-pretreated rats by altering pulmonary 
function during exposure. Still, these findings point to enhanced cardiopulmonary 
susceptibility to PM in this model of cardiomyopathy. Others have found that carbon black 
PM increases parasympathetic HRV indices in a mouse model of terminal senescence, but 
not in younger adult mice (Tankersley et al. 2004). Air pollutant susceptibility and 
parasympathetic responses may also be associated in humans. Exposure of coronary heart 
disease patients—but not healthy—patients to DE caused near-significant increases in a 
HRV parameter (pNN50, P= 0.07) (Mills et al. 2011). Likewise, ambient PM2.5 correlated 
with increased RMSSD in elderly patients with cardiopulmonary diseases—effects the 
authors noted could promote bradyarrhythmias and hypotension (Pope et al. 1999). These 
observations in humans and animals appear to conflict with the prevailing view that PM 
exposure compromises cardiovascular function through sympathetic dominance (Brook et al. 
2010). However, we recently found evidence that air pollutants may cause time-dependent 
oscillations between sympathetic and parasympathetic dominance. Specifically, a brief 
sympathetic dominance during DE exposure was followed shortly after exposure by 
parasympathetic dominance and one day later by sympathetic dominance (Carll et al. 
2013a). This prior study used time-matched sham exposures and exercise stress tests that 
likely enhanced the sensitivity of our analyses. In contrast, our current study did not include 
a full 5-h sham exposure to normalize for each rat's stress responses to nose-only restraint, 
nor did it use exercise challenges to evoke periods of uniform physiological conditions 
before and after exposure. Accordingly, we saw no significant effects on BP and HR over the 
60 hours following PM exposure, and HRV effects were restricted to the first 4 hours after 
exposure. Although it is plausible that the various air pollutants we have examined differ in 
their physiological effects, it is also likely that certain procedures, including stress tests and 
sham exposures, can unmask latent changes in autonomic and cardiovascular physiology. 
Thus, the parasympathetic effects of PM that we observed herein may only represent a 
fraction of the autonomic imbalance incurred by PM exposure.
The parasympathetic dominance and bradyarrhythmias that we observed may result from the 
stimulation of receptors and sensory nerve fiber pathways that propagate autonomic 
imbalance. Two candidate mechanisms include the triggering of acute pulmonary irritant 
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reflexes and the activation of myocardial stretch receptors (Carll et al. 2013b; Hazari et al. 
2012). The activation of the transient-receptor potential ankyrin-1 (TRPA1) channel appears 
partly responsible for pulmonary-derived autonomic imbalance (Hazari et al. 2012). 
Additionally, left ventricular dilation can trigger parasympathetic mechanoreceptor reflexes 
and has been observed with inhalation exposures to carbon black or DE that also both 
increased HRV and AV block (Carll et al. 2013b; Tankersley et al. 2004; Tankersley et al. 
2008). Although the mechanism of PM-induced bradyarrhythmias remains unclear, we have 
seen positive correlations between HRV and AV block events in DE-exposed rats that may 
result from parasympathetic activation of acetylcholine-sensitive K+ channels (IKach) (Carll 
et al. 2013b; Carll et al. 2012). Moreover this phenomenon may involve transient inhibition 
of sinoatrial node-specific vagal neurons, as demonstrated in mice exposed to iron-rich PM 
(Pham et al. 2009), which could cause heart block during parasympathetic reflexes (James et 
al. 1980). The potential for IKach blockade or broadcast vagal inhibition to mitigate these 
effects deserves further investigation.
Similar to our prior studies, cardiomyopathic remodeling was induced in heart failure-prone 
rats via continuous sub-chronic infusion of the synthetic catecholamine isoproterenol (Carll 
et al. 2010; Carll et al. 2011a). Previously, a 4-wk infusion of ISO at 2.5 mg/kg/d caused 
cardiomyopathic changes (degenerating myofibers, mixed inflammatory cells, proliferating 
fibroblasts, and fibrosis) and attendant functional changes including decreases in HR and 
contractility assessed by PEP (Carll et al. 2010; Carll et al. 2011a). Because of premature 
mortality in the previous study (Carll et al. 2011a), we reduced the daily dose to 1 mg/kg 
and prolonged infusion to 5 wk in our current study. During infusion, this new regimen 
increased HR (32% increase) and contractility (13% decrease in PEP) comparable to our 
past regimen, suggesting a similar extent of pharmacologic activation of β1 adrenergic 
receptors. We also observed a 3-day hypotension during infusion that was consistent with 
prior findings that ISO causes a transient vasodilation through β2 adrenergic activation that 
dissipates with β2 downregulation (Brouri et al. 2002; Brouri et al. 2004; Nanoff et al. 1989). 
The pathologic implications of these effects are unclear; nevertheless, gross cardiac lesions 
and telemetry data indicate that ISO infusion caused post-treatment cardiomyopathy, 
including decreased contractility, increased heterogeneity of transmural repolarization 
(TpTe) and delayed atrioventricular conduction (PR). TpTe has been shown to correlate with 
post-infarct LV remodeling (Szydlo et al. 2010) and hypertrophic cardiomyopathy 
(Savelieva et al. 1998) while also predicting ventricular tachycardia and sudden cardiac 
death in patients with hypertrophic cardiomyopathy (Shimizu et al. 2002). Furthermore, we 
have found that PR interval increases between related rat strains with increasing propensity 
for cardiomyopathy, including young adult WKY, SH, and SHHF rats as well as the aged 
SHHF (Carll et al. 2012; Carll et al. 2013b). Although histopathology was not performed in 
the current study, we previously demonstrated that infused ISO elicits significant 
cardiomyopathy (Carll et al. 2010; Carll et al. 2011a). Similarly, a 2-wk ISO infusion in rats 
at a 28% lower dose than our current regimen caused a virtually identical distribution and 
magnitude of fibrosis as with our prior regimen (Brouri et al. 2004). Like our prior regimen, 
the current one caused gross lesions on the cardiac apices of all ISO-treated rats, which we 
previously confirmed to be dense areas of myocardial fibrosis and thus pathognomonic of 
ISO-induced cardiomyopathy (Carll et al. 2010; Carll et al. 2011a).
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As with our past study (Carll et al. 2010), the period after ISO infusion corresponded with 
substantial decreases in HR and contractility (HR: ‐10% vs. -9% previously; PEP: +9% vs. 
+7% previously) which, incidentally, was accompanied by increased body mass potentially 
due to renin-angiotensin-aldosterone system-induced hypervolemia. Collectively, these 
findings indicate that prolonging ISO infusion and decreasing the daily dose induces similar 
cardiac dysfunction and injury while avoiding premature mortality. Likewise, prolonging 
infusion of ISO from 4wk to 6wk at a comparable dose has been shown to further exacerbate 
systolic failure in Wistar rats (Takeshita et al. 2008). The decrease in HR and PEP after ISO 
may have been due to down-regulation of β1-adrenoceptors, which are mediators of 
sympathetic augmentation of contractility and HR. β1 down-regulation, decreased 
contractility, and cardiomyopathy are all common pathologic traits of heart failure, which 
often results from myocardial injury causing a compensatory increase in endogenous 
catecholamines that promote myocardial remodeling and thereby eventually decrease 
ventricular ejection and filling. Given that ISO increased plasma BNP overall while 
decreasing PEP and HR, this model of ISO-induced cardiomyopathy likely recapitulates 
several key facets of heart failure. Thus, the effects of PM exposure that we observed in ISO-
pretreated rats might have clinical relevance to the epidemiological associations between 
ambient PM exposure and exacerbation of heart failure.
Likewise, we have previously demonstrated that either ISO-induced cardiomyopathy or 
advanced age in heart failure-prone rats enhances the pulmonary inflammation and 
cardiopulmonary responses elicited by PM or DE exposure (Carll et al. 2010; Carll et al. 
2013b). Research suggests this propagates autonomic imbalance, especially when transition 
metals are involved. For instance, exposure of healthy men to traffic-derived PM correlated 
with increased HRV (SDNN and pNN50), supraventricular ectopic beats, and pulmonary 
neutrophils (Riediker et al. 2004a; Riediker et al. 2004b; Riediker 2007), which the authors 
found were primarily mediated by copper, sulfur, and aldehydes. Accordingly, transition 
metal content, not total mass, has been found to mediate PM-induced pulmonary oxidative 
stress and inflammation (Costa and Dreher 1997). Recent research has demonstrated that 
nickel-sulfate inhalation increases HRV and beat-to-beat interval dependent on oxidative 
stress and inflammation (Chuang et al. 2013). In the present study, PM exposure caused 
greater cardiopulmonary inflammation in rats with ISO-induced cardiomyopathy than in 
saline-treated rats. Nevertheless, it remains unclear whether the pulmonary inflammatory 
effects of PM in ISO-pretreated rats mediated the overt parasympathetic responses. Notably, 
because parasympathetic activation is anti-inflammatory (Pavlov and Tracey 2005; Thayer 
2009), it is possible that the increases in HRV reflect innate neural defense mechanisms 
against pro-inflammatory agents. This may partly explain our past observations of air 
pollutant-induced autonomic imbalance that were unaccompanied by detectable 
cardiopulmonary inflammation or oxidative stress (Carll et al. 2010; Carll et al. 2013a). Our 
findings merit deeper exploration into the anti- and pro-inflammatory effects as well as the 
mechanistic origins of pollutant-induced autonomic imbalance.
The short- and long-term effects that acute PM exposure had on pulmonary antioxidants 
offer novel insight to potential mechanisms of air pollutant toxicity. Exposure to PM in ISO-
pretreated rats acutely increased total antioxidants within the lung lining fluid. This effect 
was consistent with an acute antioxidant defense response that others have noted with 
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pulmonary inflammation from hyperoxia or mineral dust exposure (Quinlan et al. 1994). 
Interestingly, two months after this single acute exposure, PM persistently decreased 
pulmonary glutathione peroxidase, a major antioxidant enzyme, only in rats with ISO-
induced cardiomyopathy. Thus, preexisting cardiomyopathy conferred susceptibility to PM-
induced chronic depletion of antioxidants within the lung lining fluid. Moreover, the data 
indicate that acute exposure to PM can impair pulmonary defenses long after exposure. 
Given the prolonged effect of this single exposure on glutathione peroxidase, it seems 
plausible that repeat exposure would further enhance cardiopulmonary susceptibility in our 
model of cardiomyopathy by cumulatively depleting antioxidants. Whether the transition 
metal content of sROFA PM mediated this effect remains unknown. These findings merit 
further investigation into whether and how acute PM exposure may chronically enhance 
susceptibility to pulmonary injury.
Taken together, a single 4-hour inhalation exposure to a ROFA-like PM caused more 
cardiopulmonary responses in a rat model of drug-induced cardiomyopathy than in rats 
without cardiomyopathy. These responses included immediate decreases in BP and 
prolonged PR-interval, subsequent vagal dominance and—concomitantly—
bradyarrhythmias, and later pulmonary inflammation and oxidative stress. The possibility 
that such changes can lead to adverse health effects and whether these responses in rats 
translate to human responses is unclear. Nevertheless, exaggerated sensitivity to PM in rats 
with cardiomyopathy is consistent with the pattern observed in heart failure patients. 
Ultimately, this study demonstrates that preexisting cardiac remodeling confers 
susceptibility to the cardiopulmonary effects of air pollution and may help elucidate the 
mechanisms by which PM exposure exacerbates heart failure in man.
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Effects of chronic ISO infusion on HR and aortic systolic, diastolic, and pulse pressures 
before exposure to PM. Solid lines indicate 4-h means of ISO- (black, n = 10) or saline-
treated (gray, n = 11) rats, and are bordered by dashed lines indicating standard error. Stars 
and brackets mark periods of consistent significant differences from saline group, while 
individual stars indicate group differences for single 4-h means between saline and ISO-
treated animals. For HR n = 13 for Saline and n = 11 for ISO, while for all pressure-derived 
parameters n = 9 for Saline and n=10 for ISO.
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Effects of chronic ISO infusion on pre-ejection period (an inverse index of cardiac 
contractility) before exposure to PM. Solid lines indicate 4-h means of ISO- (black, n = 10) 
or saline-treated (gray, n = 9) rats, and are bordered by dashed lines indicating standard 
error. Stars and brackets mark periods of consistent significant differences from saline 
group, while individual stars indicate group differences for single 4-h means between saline 
and ISO-treated animals.
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Effects of PM inhalation on 1-h group means of ECG PR interval and Systolic BP during a 4 
h nose-only exposure. Baseline and Recovery represent 40-min periods before initiation and 
after cessation of particle or filtered air exposure. Star indicates significant difference from 
Sal-PM. Diamond represents significant difference from ISO-Air (P < 0.05). N = 4-5 per 
group.
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PM inhalation increased tidal volume, expiratory time, and relaxation time only in ISO-
pretreated animals. Values represent group means (± standard error) immediately after nose-
only inhalation exposure (“Post-Inhal”) or the time-matched period on the preceding day 
(“Pre-Inhal”) after a 2-h acclimation to nose-only restraint. Star indicates significant 
difference between values indicated by bracket (P < 0.05). N = 5 per group.
Carll et al. Page 21














ISO alters the HR and HRV effects of a 4 h nose-only PM inhalation. Data represents each 
group's mean change (± standard error) at the 7 h immediately after exposure relative to its 
own values on the preceding day at the same time. During both monitoring periods, animals 
resided in home cages. Star indicates significant difference from Sal-PM (P < 0.05). 
Diamond represents significant difference from ISO-Air (P < 0.05). N = 5 per group.
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PM inhalation increased AV block arrhythmias only in ISO-pretreated animals. Values 
represent group means (± standard error) over the 7 h after nose-only inhalation exposure or 
the time-matched 7-h period on the preceding day (“Pre-Inhalation”). Star indicates 
significant difference from Sal-PM (P < 0.05). Diamond represents significant difference 
from ISO-Air (P < 0.05). N = 5 per group.
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Markers of cardiopulmonary inflammation (neutrophils and macrophages), antioxidant 
response (total antioxidant status), and myocardial stretch (BNP) at 1 d post-exposure to PM 
or filtered air in saline- or ISO-pretreated rats. Means ± standard error, n = 4-5 / group. Stars 
and brackets represent significant differences between groups (P < 0.05). Omega indicates a 
significant overall effect of ISO on BNP as detected by two-way ANOVA (P=0.01).
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Endogenous antioxidants (pulmonary glutathione peroxidase and serum glutathione S-
transferase) at 8 weeks after a single 4-h exposure to PM or filtered air in saline- or ISO-
pretreated rats. Means ± standard error, n = 6-7 per group. Star and bracket represents 
significant difference between groups (P < 0.05).
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